Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
SAF Farma Georgia — the Georgian arm (since 2015) of SAF Farma, a pharmaceutical marketing and brand-representation group founded in Azerbaijan in 2004 and also active in Ukraine and Uzbekistan (saffarma.ge). Imports and markets innovative branded medications across ophthalmology, therapy, neurology, gynaecology and paediatrics.
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|
| Net Cash from Operating Activities | 32 | 330 | 377 | 379 | 100 | 0 | 485 | +57.0% |
| Net Cash used in Investing Activities | 11 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Free Cash Flow (OCF − Capex proxy) | 21 | 330 | 377 | 379 | 100 | 0 | 485 | +68.5% |
| Net Cash from Financing Activities | 41 | 214 | 493 | 193 | 289 | 0 | 0 | +62.7% |
| Net Change in Cash (before FX) | 20 | 116 | 116 | 186 | 189 | 0 | 485 | nmf |
| Effect of FX on Cash | 5 | 0 | 0 | 0 | 0 | 0 | 29 | nmf |
| Net Change in Cash (incl. FX) | 15 | 116 | 116 | 186 | 189 | 0 | 456 | nmf |
| Cash at Beginning of Year | 18 | 4 | 120 | 3 | 190 | 1 | 0 | -45.1% |
| Cash at End of Year | 4 | 120 | 3 | 190 | 1 | 0 | 457 | nmf |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →